Share this Post!

Please be informed that the Center for Drug Regulation and Research (CDRR) will be having its 2023 CDRR Midyear Program Implementation Review (PIR) on 18-22 September 2023. All workforce is required to attend the activity.

Regular operation will resume on 25 September 2023.

Given this, we advise our clients to send all queries and concerns via e-mail:   cdrr.od@fda.gov.ph and we will respond accordingly.

To know the latest status of your application/request, kindly visit https://www.fda.gov.ph/kiosk/.

For application through eServices, you may check and visit the following for the latest status:

For your guidance.

Attachments